Oscar Health hires CFO

Oscar Health, the New York-based startup health insurance provider with more than $1 billion in funding, has named Sid Sankaran as its new chief financial officer, effective March 1.

Sankaran succeeds CFO Brian West, who left the company in November 2018.

“Sid embodies an unmatched breadth and depth of experience in subjects critical to any company, such as capital and strategy, as well as those particularly important at Oscar, such as actuarial and risk,” Mario Schlosser, CEO and co-founder at Oscar, said in a statement. “Sid will be a valuable addition to Oscar as we work to expand our footprint, grow our membership, and offer consumers accessible, affordable care.”

Sankaran served as executive vice president and CFO at AIG, overseeing a balance sheet of nearly $500 million. He also previously served as AIG’s chief risk officer for five years. He was formerly a partner at Oliver Wyman Financial Services, a finance and risk practice, prior to working at AIG.

Oscar Health has grabbed headlines for its large funding rounds, including from Google parent company Alphabet, which invested $375 million in the company last year. The insurer has a focus on patient-centered care and telemedicine services. Its founders, Mario Schlosser and Joshua Kushner––brother of Trump aide Jared Kushner––were recognized in Time Magazine’s 50 most influential people in healthcare for 2018.

In his new role, Sankaran will oversee accounting, financial planning and analysis, strategic finance, actuarial, pricing and plan design at the company, according to the announcement.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.